Patents by Inventor Gohar Azhar

Gohar Azhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using a serum response factor isoform
    Patent number: 9365856
    Abstract: The present invention encompasses methods of administering SRF?3. Administering SRF?3 may reduce proliferation of cancer cells, and modulate activity of promoters regulated by serum response factor.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: June 14, 2016
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Jeanne Wei, Gohar Azhar, Xiaomin Zhang
  • METHODS OF USING A SERUM RESPONSE FACTOR ISOFORM
    Publication number: 20140080123
    Abstract: The present invention encompasses methods of administering SRF?3. Administering SRF?3 may reduce proliferation of cancer cells, and modulate activity of promoters regulated by serum response factor.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 20, 2014
    Inventors: Jeanne Wei, Gohar Azhar, Xiaomin Zhang
  • Method of screening for agents to treat heart failure
    Patent number: 8043801
    Abstract: The invention provides a method of identifying candidate agents to test for treating heart failure involving diastolic impairment, the method comprising: testing an agent to determine whether it (a) binds to serum response factor (SRF), (b) reduces SRF binding to a serum response element (SRE), or (c) reduces SRF protein levels in a cell; wherein if the agent does one or more of (a), (b), and (c), it is identified as a candidate agent.
    Type: Grant
    Filed: November 22, 2008
    Date of Patent: October 25, 2011
    Inventors: Jeanne Y. Wei, Gohar Azhar, Xiaomin Zhang
  • Method of screening for agents to treat heart failure
    Publication number: 20090187998
    Abstract: The invention provides a method of identifying candidate agents to test for treating heart failure involving diastolic impairment, the method comprising: testing an agent to determine whether it (a) binds to serum response factor (SRF), (b) reduces SRF binding to a serum response element (SRE), or (c) reduces SRF protein levels in a cell; wherein if the agent does one or more of (a), (b), and (c), it is identified as a candidate agent.
    Type: Application
    Filed: November 22, 2008
    Publication date: July 23, 2009
    Inventors: Jeanne Y. Wei, Gohar Azhar, Xiaomin Zhang